92 related articles for article (PubMed ID: 25224727)
1. Heterogeneity of triple-negative breast cancer: mammographic, US, and MR imaging features according to androgen receptor expression.
Bae MS; Park SY; Song SE; Kim WH; Lee SH; Han W; Park IA; Noh DY; Moon WK
Eur Radiol; 2015 Feb; 25(2):419-27. PubMed ID: 25224727
[TBL] [Abstract][Full Text] [Related]
2. Androgen receptor positive triple negative breast cancer: Clinicopathologic, prognostic, and predictive features.
Astvatsaturyan K; Yue Y; Walts AE; Bose S
PLoS One; 2018; 13(6):e0197827. PubMed ID: 29883487
[TBL] [Abstract][Full Text] [Related]
3. Ultrasound-based comparative analysis and nomogram development for predicting triple-negative and non-triple-negative breast cancer: a 4-year institutional study in Quanzhou First Hospital.
Su L; Xie Q; Chen J; Zhang Q; Li N; Hong C
BMJ Open; 2024 Jun; 14(6):e085340. PubMed ID: 38871659
[TBL] [Abstract][Full Text] [Related]
4. Incidence and Prognostic Significance of Androgen Receptors (AR) in Indian Triple-Negative Breast Cancer (TNBC).
Mishra A; Mishra SK; Sharanappa V; Krishnani N; Kumari N; Agarwal G
Indian J Surg Oncol; 2024 Jun; 15(2):250-257. PubMed ID: 38741650
[TBL] [Abstract][Full Text] [Related]
5. Androgen Receptor Expression and Its Correlation with Clinicopathological Parameters in Iranian Patients with Triple Negative Breast Cancer.
Naimi A; Soltan M; Amjadi E; Goli P; Kefayat A
Iran J Pathol; 2020; 15(3):239-244. PubMed ID: 32754220
[TBL] [Abstract][Full Text] [Related]
6. Imaging Patterns in Breast Cancer for Women Under 40 Years: A Descriptive Cohort Study.
Alhaidary AA; Al-Qudimat AR; Arabi H; Al-Zoubi RM
J Epidemiol Glob Health; 2024 Mar; 14(1):63-71. PubMed ID: 38206550
[TBL] [Abstract][Full Text] [Related]
7. Association of imaging and pathological findings of breast cancer in very young women: Report of a twenty-year retrospective study.
Sefidbakht S; Beizavi Z; Kanaani Nejad F; Pishdad P; Sadighi N; Ghoddusi Johari M; Bijan B; Tahmasebi S
Clin Imaging; 2024 Jun; 110():110094. PubMed ID: 38599926
[TBL] [Abstract][Full Text] [Related]
8. Triple Negative Breast Cancers: An Obsolete Entity?
Keskinkılıc M; Gökmen-Polar Y; Badve SS
Clin Breast Cancer; 2024 Jan; 24(1):1-6. PubMed ID: 38016912
[TBL] [Abstract][Full Text] [Related]
9. Anti-androgen therapy in triple-negative breast cancer.
Barton VN; Gordon MA; Richer JK; Elias A
Ther Adv Med Oncol; 2016 Jul; 8(4):305-8. PubMed ID: 27482289
[No Abstract] [Full Text] [Related]
10. Correlation of androgen receptor with ultrasound, clinicopathological features and clinical outcomes in breast cancer.
Zhang X; Cui H; Hu N; Han P; Fan W; Wang P; Zuo X; Zhao D; Huang H; Li S; Kong H; Peng F; Tian J; Zhang L
Insights Imaging; 2023 Mar; 14(1):46. PubMed ID: 36929229
[TBL] [Abstract][Full Text] [Related]
11. Malignant Apocrine Lesions of the Breast: Multimodality Imaging Findings and Biologic Features.
Lee HJ; Kang SW; Lee JE; Jeong WG; Lee JS; Park MH; Lim HS
J Breast Cancer; 2022 Dec; 25(6):513-521. PubMed ID: 36479602
[TBL] [Abstract][Full Text] [Related]
12. Characterization of breast cancer subtypes based on quantitative assessment of intratumoral heterogeneity using dynamic contrast-enhanced and diffusion-weighted magnetic resonance imaging.
Kim JJ; Kim JY; Suh HB; Hwangbo L; Lee NK; Kim S; Lee JW; Choo KS; Nam KJ; Kang T; Park H
Eur Radiol; 2022 Feb; 32(2):822-833. PubMed ID: 34345946
[TBL] [Abstract][Full Text] [Related]
13. Clinical Implications of Androgen-Positive Triple-Negative Breast Cancer.
Brumec M; Sobočan M; Takač I; Arko D
Cancers (Basel); 2021 Apr; 13(7):. PubMed ID: 33915941
[TBL] [Abstract][Full Text] [Related]
14. Combining Diagnostic Imaging and Pathology for Improving Diagnosis and Prognosis of Cancer.
Schillaci O; Scimeca M; Toschi N; Bonfiglio R; Urbano N; Bonanno E
Contrast Media Mol Imaging; 2019; 2019():9429761. PubMed ID: 31354394
[TBL] [Abstract][Full Text] [Related]
15. Imaging features of triple-negative breast cancers according to androgen receptor status.
Candelaria RP; Adrada BE; Wei W; Thompson AM; Santiago L; Lane DL; Huang ML; Arribas EM; Rauch GM; Symmans WF; Gilcrease MZ; Huo L; Lim B; Ueno NT; Moulder SL; Yang WT
Eur J Radiol; 2019 May; 114():167-174. PubMed ID: 31005169
[TBL] [Abstract][Full Text] [Related]
16. Role of DCE-MR in predicting breast cancer subtypes.
Macchini M; Ponziani M; Iamurri AP; Pistelli M; De Lisa M; Berardi R; Giuseppetti GM
Radiol Med; 2018 Oct; 123(10):753-764. PubMed ID: 29869226
[TBL] [Abstract][Full Text] [Related]
17. Investigation of Association Between Borderline Pancreatic Head Cancer and Glucose Uptake by Using Positron-Emission Tomographic Studies.
Zhang Y; Qin L; Zhang C
Med Sci Monit; 2017 Oct; 23():4947-4953. PubMed ID: 29036034
[TBL] [Abstract][Full Text] [Related]
18. Contrast Enhancement on Cone-Beam Breast-CT for Discrimination of Breast Cancer Immunohistochemical Subtypes.
Uhlig J; Fischer U; von Fintel E; Stahnke V; Perske C; Lotz J; Wienbeck S
Transl Oncol; 2017 Dec; 10(6):904-910. PubMed ID: 28946110
[TBL] [Abstract][Full Text] [Related]
19. Clinical predictors of pathological complete response to neoadjuvant chemotherapy in triple-negative breast cancer.
Nakashoji A; Matsui A; Nagayama A; Iwata Y; Sasahara M; Murata Y
Oncol Lett; 2017 Oct; 14(4):4135-4141. PubMed ID: 28943920
[TBL] [Abstract][Full Text] [Related]
20. Cone-beam Breast Computed Tomography: CT Density Does Not Reflect Proliferation Potential and Receptor Expression of Breast Carcinoma.
Wienbeck S; Fischer U; Perske C; Wienke A; Meyer HJ; Lotz J; Surov A
Transl Oncol; 2017 Aug; 10(4):599-603. PubMed ID: 28666188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
